Valeant sacks Dendreon admin staff and plans manufacturing savings
Valeant has started cutting jobs at Provenge manufacturer Dendreon just over a week after it acquired the bankrupt firm for $495m (€444m).
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs